Cargando…
Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes
BACKGROUND: Myelodysplastic syndromes (MDS) encompass a group of heterogeneous haematopoietic stem cell malignancies characterised by ineffective haematopoiesis, cytological aberrations, and a propensity for progression to acute myeloid leukaemia. Diagnosis and disease prognostic stratification are...
Autores principales: | Qin, Yao, Zhang, Hang, Feng, Lin, Wei, Haichen, Wu, Yuling, Jiang, Chaoran, Xu, Zhihong, Zhu, Huanling, Liu, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518301/ https://www.ncbi.nlm.nih.gov/pubmed/36148999 http://dx.doi.org/10.1080/07853890.2022.2125173 |
Ejemplares similares
-
Metaphase cytogenetics and single nucleotide polymorphism arrays in myeloid malignancies()
por: da Silva, Fernanda Borges, et al.
Publicado: (2015) -
Copper and Zinc Feud: Is This Myelodysplasia or Myelodysplastic Syndrome?
por: Kumar, Manoj, et al.
Publicado: (2022) -
Methotrexate-induced myelodysplasia mimicking myelodysplastic syndrome
por: Kawase, Yuuki, et al.
Publicado: (2018) -
Complex cytogenetics in a patient with mixed-phenotype acute leukemia
por: Mansoori, Huma, et al.
Publicado: (2016) -
Multiple myeloma with high-risk cytogenetics and its treatment approach
por: Hanamura, Ichiro
Publicado: (2022)